Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000386233

Medchemexpress LLC LYG-409 | 3053857-55-6 | 98.1% | 515.44 | 5 MG
SDP

Catalog No. 5000386233
Encompass_Preferred

LYG-409 is an orally active degrader of GSPT1. It demonstrates excellent anti-acute myeloid leukemia and prostate cancer activity in vivo, with TGI percentages of 94.34% and 104.49%, respectively. In vitro, it inhibits KG-1 cells through the degradation of GSPT1, showing an IC50 of 9.50 nM and a DC50 of 7.87 nM.

  • Orally active degrader of GSPT1.
  • Exhibits anti-acute myeloid leukemia and prostate cancer activity in vivo.
  • Inhibits KG-1 cells by degrading GSPT1.

Catalog No. 50-003-86233 Supplier Medchemexpress LLC Supplier No. HY1709525MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

LYG-409 is an orally active degrader of GSPT1. It demonstrates excellent anti-acute myeloid leukemia and prostate cancer activity in vivo, with TGI percentages of 94.34% and 104.49%, respectively. In vitro, it inhibits KG-1 cells through the degradation of GSPT1, showing an IC50 of 9.50 nM and a DC50 of 7.87 nM.

  • Orally active degrader of GSPT1.
  • Exhibits anti-acute myeloid leukemia and prostate cancer activity in vivo.
  • Inhibits KG-1 cells by degrading GSPT1.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.